Second-Generation Bruton's Tyrosine Kinase Inhibitors: Simply the Best Treatments for Chronic Lymphocytic Leukemia?

J Clin Oncol. 2021 Nov 1;39(31):3419-3422. doi: 10.1200/JCO.21.01414. Epub 2021 Jul 26.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Comment

MeSH terms

  • Agammaglobulinaemia Tyrosine Kinase
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell* / drug therapy
  • Protein Kinase Inhibitors / adverse effects
  • Pyrimidines / adverse effects

Substances

  • Protein Kinase Inhibitors
  • Pyrimidines
  • Agammaglobulinaemia Tyrosine Kinase